Primary Site >> Pancreatic Cancer

Gene >> NPTX2

  • 2003
  • 2006
  • 2007
  • 2008
  • 2011
  • 2012
  • 2013
  • 2017
  • 2018
Ref: Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.
PMID: 12839967
Ref: DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
PMID: 16424060
Ref: Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer.
PMID: 17895837
Ref: CpG island methylation profile of pancreatic intraepithelial neoplasia.
PMID: 18157091
Ref: DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease.
PMID: 18995218
Ref: The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro.
PMID: 21161403
Ref: The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
PMID: 21778928
Ref: Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
PMID: 22414467
Ref: Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers.
PMID: 22806544
Ref: NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms.
PMID: 23360791
Ref: Methylation of Tumor Suppressor Genes in Autoimmune Pancreatitis.
PMID: 28196014
Ref: Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma.
PMID: 29212200
Ref: Early Epigenetic Markers for Precision Medicine.
PMID: 30178243